Biosafety and Genomic Epidemiological Surveillance

The problem of biological safety is extremely relevant today for all countries of the world because of the real and potential threats caused by biological agents that are dangerous to public health and the environment. Modern microorganisms are becoming increasingly aggressive towards humans, as clearly demonstrated by the COVID-19 pandemic, which has affected all aspects of people's lives and exposed the vulnerability of the healthcare system. According to the Decree of the President of the Russian Federation «On the Fundamentals of the State policy of the Russian Federation in the field of chemical and biological safety for the period up to 2025 and beyond» and the Federal Law «On Biological Safety in the Russian Federation», the main objectives of state policy are to reduce the risks of negative effects of biological factors on the population and the environment. Antimicrobial resistance, the emergence of new infections and the overcoming of interspecific barriers by microorganisms are of particular concern. Infectious disease agents with epidemic potential, such as Ebola, Zika, Marburg, Lassa, MERS-CoV and SARS-CoV viruses, continue to pose a high threat. To counteract new biological threats, Russia has created a scientific concept of future biosafety, focusing on the development of genomic epidemiological surveillance, digital transformation and mobile technologies. Effective management of epidemic processes requires constant monitoring of genetic changes in infectious agents and prompt response to new threats, which allows the VGARus platform created in Russia to monitor virus mutations. Thus, genomic epidemiological surveillance is becoming a key element of ensuring biological safety and scientific and technological development in Russia.

1. Akimkin V.G., Zverev V.V., Kirpichnikov M.P., et al. Epidemiological, cellular, genetic and epigenetic aspects of biosafety. Vestnik Rossijskoj akademii nauk. - 2024. - Vol. 94. - N. 3. - P. 287–298. (In Russ). doi:10.31857/S0869587324030127.

2. Lyapin M.N., Kutyrev V.V. Actual problems of biosafety. Journal of microbiology, epidemiology and immunobiology. 2013; 90 (1): 97–102. (In Russ).

3. Akimkin VG, Semenenko TA, Dubodelov DV, et al. The Theory of Self-Regulation of Parasitary Systems and COVID-19. Annals of the Russian Academy of Medical Sciences. 2024;79(1):33–41. (In Russ.) doi:10.15690/vramn11607

4. Belashchenko D.A., Shodzhonov I.F. Revisiting the Guarantees of the Bio-Political Sovereignty of the Russian Federation. Via in tempore. History and political science 2023; 50(4): 1084–1094. (in Russ). doi:10.52575/2687-0967-2023-50-4-1084-1094

5. Semenenko T.A. The role of the blood serum bank in the biological safety system of the country. Bulletin of Roszdravnadzor. 2010;(3):55–8. (In Russ.)

6. Orekhov S.N., Mokhov A.A., Yavorsky A.N. Antimicrobial resistance: a risk factor for the biosafety system. Safety and Risk of Pharmacotherapy. 2023;11(3):336–347. (in Russ). doi:10.30895/2312-7821-2023-11-3-336-347

7. COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report 2022. Centers for Disease Control and Prevention, National Center for Emerging and Zoonotic Infectious Diseases, Division of Healthcare Quality Promotion; 2022. doi:10.15620/cdc:117915

8. Bracing for Superbugs. Strengthening environmental action in the One Health response to antimicrobial resistance. 2023 United Nations Environment Programme. Available at: https://www.unep.org/resources/superbugs/environmental-action. Accessed: 4 August 2024.

9. WHO. 2021 AWaRe classification. Available at: https://www.who.int/publications/i/item/2021-aware-classification. Accessed: 4 August 2024.

10. WHO Updates Blueprint List of Priority Diseases. Available at: https://globalbiodefense.com/2018/02/12/who-updates-blueprint-list-of-priority-diseases/. Accessed: 4 August 2024.

11. What Is Disease X? The Pandemic Threat Discussed At Davos 2024. Available at: https://www.forbes.com/sites/brucelee/2024/01/27/what-is-disease-x-the-pandemic-threat-discussed-at-davos-2024/. Accessed: 4 August 2024.

12. Rospotrebnadzor commented on the statements about «disease X». Available at: https://ria.ru/20240114/bolezn-1921282909.html. Accessed: 4 August 2024.

13. Suzuki, R., Yamasoba, D., Kimura, I. et al. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant. Nature 603, 700–705 (2022). doi:10.1038/s41586-022-04462-1

14. Willett, B.J., Grove, J., MacLean, O.A. et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol 7, 1161–1179 (2022). doi:10.1038/s41564-022-01143-7

15. Willett, B.J., Grove, J., MacLean, O.A. et al. SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway. Nat Microbiol 7, 1161–1179 (2022). doi:10.1038/s41564-022-01143-7

16. Dejnirattisai W, Huo J, Zhou D, et al. SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses. Cell. 2022;185(3):467–484.e15. doi:10.1016/j.cell.2021.12.046

17. Tegally, H., Moir, M., Everatt, J. et al. Emergence of SARS-CoV-2 Omicron lineages BA.4 and BA.5 in South Africa. Nat Med 28, 1785–1790 (2022). doi:10.1038/s41591-022-01911-2

18. The future of Biosafety at the Forum of Future Technologies on 02/13/2024 Available at: https://rospotrebnadzor.ru/about/info/news/news_details.php?ELEMENT_ID=26987. Accessed: 4 August 2024.

19. Global genomic surveillance strategy for pathogens with pandemic and epidemic potential 2022–2032. Available at: https://www.who.int/initiatives/genomic-surveillance-strategy. Accessed: 4 August 2024.

20. Carter L.L., Yu M.A., Sacks J.A., et al. Global genomic surveillance strategy for pathogens with pandemic and epidemic potential, 2022–2032. Bull. World Health Organ. 2022;100(4):239–A. doi:10.2471/blt.22.288220

21. Akimkin V.G., Semenenko T.A., Ugleva S.V., et al. COVID-19 in Russia: epidemiology and molecular genetic monitoring. Annals of the Russian Academy of Medical Sciences. 2022;77(4):254–60. (in Russ). doi:10.15690/vramn2121

22. Akimkin, V., Semenenko, T.A., Ugleva, S.V., et al. COVID-19 Epidemic Process and Evolution of SARS-CoV-2 Genetic Variants in the Russian Federation. Microbiol. Res. 2024, 15, 213–224. doi:10.3390/microbiolres15010015

23. Kotov I.A., Agletdinov M.R., Roev G.V., et al. Genomic Surveillance of SARS-CoV-2 in Russia: Insights from the VGARus Platform. Journal of microbiology, epidemiology and immunobiology. - 2024. - Vol. 101. - N. 4. - P. 435–447. doi:10.36233/0372-9311-554

24. Berman A.M. Impact of biological challenges on social and political relations: issues and prospects, The Territory of New Opportunities. The Herald of Vladivostok State University of Economics and Service, 2020, Vol. 12, № 4, pp. 79–87. doi:10.24866/VVSU/2073-3984/2020-4/079-087

25. Akimkin V.G., Semenenko T.A., Khafizov K.F., et al. Genomic surveillance strategy. Problems and perspectives. Journal of microbiology, epidemiology and immunobiology. 2024;101(2):163–172. (in Russ). doi:10.36233/0372-9311-507

26. WHO Director-General’s High-Level Welcome at the Seventy-seventh World Health Assembly – 27 May 2024. Available at: https://www.who.int/director-general/speeches/detail/who-director-general-s-high-level-welcome-at-the-seventy-seventh-world-health-assembly-27-may-2024. Accessed: 4 August 2024.

27. Pandemic prevention, preparedness and response accord. Available at: https://www.who.int/ru/news-room/questions-and-answers/item/pandemic-prevention--pre-paredness-and-response-accord. Accessed: 4 August 2024.

28. World Health Assembly agreement reached on wide-ranging, decisive package of amendments to improve the International Health Regulations. Available at: https://www.who.int/news/item/01-06-2024-world-health-assembly-agreement-reached-on-wide-ranging--decisive-package-of-amendments-to-improve-the-international-health-regulations--and-sets-date-for-finalizing-negotiations-on-a-proposed-pandemic-agreement. Accessed: 4 August 2024.